Grifols plans to invest $402 million in new industrial centre, El Economista says
Sept 30 (Reuters) -Spanish drugmaker Grifols GRLS.MC plans to invest 360 million euros ($401.98 million) to build a new industrial plant in Barcelona for its engineering department, newspaper El Economista said on Monday, citing unidentified company sources.
Grifols is seeking to centralise operations currently dispersed across different locations, El Economista said.
The works are scheduled to start next year and the facility will be ready by the end of the decade, the newspaper reported.
A spokesperson did not respond to a request for comment.
The Grifols founding family, which owns about 30% of the company, and Canadian fund Brookfield BN.TO agreed in July to evaluate a possible joint takeover bid for Grifols with the intent to delist it.
Grifols lost a third of its market value in January when short-seller fund Gotham City Research started releasing reports accusing Grifols of overstating earnings and understating debt. Following the reports Grifols announced governance changes and revised its reported leverage higher.
($1 = 0.8956 euros)
Reporting by Joanna Jonczyk-Gwizdala, Editing by Inti Landauro and Jan Harvey
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
